80 related articles for article (PubMed ID: 19592243)
21. In silico prediction of cytochrome P450 2D6 and 3A4 inhibition using Gaussian kernel weighted k-nearest neighbor and extended connectivity fingerprints, including structural fragment analysis of inhibitors versus noninhibitors.
Jensen BF; Vind C; Padkjaer SB; Brockhoff PB; Refsgaard HH
J Med Chem; 2007 Feb; 50(3):501-11. PubMed ID: 17266202
[TBL] [Abstract][Full Text] [Related]
22. Exploration of catalytic properties of CYP2D6 and CYP3A4 through metabolic studies of levorphanol and levallorphan.
Bonn B; Masimirembwa CM; Castagnoli N
Drug Metab Dispos; 2010 Jan; 38(1):187-99. PubMed ID: 19797609
[TBL] [Abstract][Full Text] [Related]
23. Demethylation of neferine in human liver microsomes and formation of quinone methide metabolites mediated by CYP3A4 accentuates its cytotoxicity.
Shen Q; Zuo M; Ma L; Tian Y; Wang L; Jiang H; Zhou Q; Zhou H; Yu L; Zeng S
Chem Biol Interact; 2014 Dec; 224():89-99. PubMed ID: 25451576
[TBL] [Abstract][Full Text] [Related]
24. Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes.
Tang L; Ye L; Lv C; Zheng Z; Gong Y; Liu Z
Toxicol Lett; 2011 Apr; 202(1):47-54. PubMed ID: 21277363
[TBL] [Abstract][Full Text] [Related]
25. Novel triple reuptake inhibitors with low risk of CAD associated liabilities: design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.
Ishichi Y; Kimura E; Honda E; Yoshikawa M; Nakahata T; Terao Y; Suzuki A; Kawai T; Arakawa Y; Ohta H; Kanzaki N; Nakagawa H; Terauchi J
Bioorg Med Chem; 2013 Aug; 21(15):4600-13. PubMed ID: 23769168
[TBL] [Abstract][Full Text] [Related]
26. Comparative study of hops-containing products on human cytochrome P450-mediated metabolism.
Foster BC; Arnason JT; Saleem A; Tam TW; Liu R; Mao J; Desjardins S
J Agric Food Chem; 2011 May; 59(9):5159-63. PubMed ID: 21476568
[TBL] [Abstract][Full Text] [Related]
27. Prediction of in vivo drug-drug interactions from in vitro data : factors affecting prototypic drug-drug interactions involving CYP2C9, CYP2D6 and CYP3A4.
Brown HS; Galetin A; Hallifax D; Houston JB
Clin Pharmacokinet; 2006; 45(10):1035-50. PubMed ID: 16984215
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and in vitro activity of 1,4-disubstituted piperazines and piperidines as triple reuptake inhibitors.
Paudel S; Acharya S; Yoon G; Kim KM; Cheon SH
Bioorg Med Chem; 2017 Apr; 25(7):2266-2276. PubMed ID: 28274674
[TBL] [Abstract][Full Text] [Related]
29. Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomib.
Uttamsingh V; Lu C; Miwa G; Gan LS
Drug Metab Dispos; 2005 Nov; 33(11):1723-8. PubMed ID: 16103134
[TBL] [Abstract][Full Text] [Related]
30. In vitro effects of active constituents and extracts of Orthosiphon stamineus on the activities of three major human cDNA-expressed cytochrome P450 enzymes.
Pan Y; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Pook PC; Er HM; Ong CE
Chem Biol Interact; 2011 Mar; 190(1):1-8. PubMed ID: 21276781
[TBL] [Abstract][Full Text] [Related]
31. Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes.
Lalovic B; Phillips B; Risler LL; Howald W; Shen DD
Drug Metab Dispos; 2004 Apr; 32(4):447-54. PubMed ID: 15039299
[TBL] [Abstract][Full Text] [Related]
32. Donepezil plasma concentrations, CYP2D6 and CYP3A4 phenotypes, and cognitive outcome in Alzheimer's disease.
Coin A; Pamio MV; Alexopoulos C; Granziera S; Groppa F; de Rosa G; Girardi A; Sergi G; Manzato E; Padrini R
Eur J Clin Pharmacol; 2016 Jun; 72(6):711-7. PubMed ID: 26952092
[TBL] [Abstract][Full Text] [Related]
33. An evaluation of the CYP2D6 and CYP3A4 inhibition potential of metoprolol metabolites and their contribution to drug-drug and drug-herb interaction by LC-ESI/MS/MS.
Borkar RM; Bhandi MM; Dubey AP; Ganga Reddy V; Komirishetty P; Nandekar PP; Sangamwar AT; Kamal A; Banerjee SK; Srinivas R
Biomed Chromatogr; 2016 Oct; 30(10):1556-72. PubMed ID: 27006091
[TBL] [Abstract][Full Text] [Related]
34. CYP450 mediated inhibition potential of Swertia chirata: An herb from Indian traditional medicine.
Ahmmed SM; Mukherjee PK; Bahadur S; Harwansh RK; Kar A; Bandyopadhyay A; Al-Dhabi NA; Duraipandiyan V
J Ethnopharmacol; 2016 Feb; 178():34-9. PubMed ID: 26657265
[TBL] [Abstract][Full Text] [Related]
35. Use of Human Plasma Samples to Identify Circulating Drug Metabolites that Inhibit Cytochrome P450 Enzymes.
Eng H; Obach RS
Drug Metab Dispos; 2016 Aug; 44(8):1217-28. PubMed ID: 27271369
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of dolasetron. Comparison with other indole-containing 5-HT3 antagonists.
Sanwald P; David M; Dow J
Drug Metab Dispos; 1996 May; 24(5):602-9. PubMed ID: 8723743
[TBL] [Abstract][Full Text] [Related]
37. A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.
Potkin SG; Preskorn S; Hochfeld M; Meng X
J Clin Psychopharmacol; 2013 Feb; 33(1):3-10. PubMed ID: 23277250
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of in vitro cytochrome P450 induction and inhibition activity of deoxyelephantopin, a sesquiterpene lactone from Elephantopus scaber L.
Koe XF; Lim EL; Seah TC; Amanah A; Wahab HA; Adenan MI; Sulaiman SF; Tan ML
Food Chem Toxicol; 2013 Oct; 60():98-108. PubMed ID: 23876819
[TBL] [Abstract][Full Text] [Related]
39. Identification of human liver cytochrome P450 isoforms involved in the in vitro metabolism of cyclobenzaprine.
Wang RW; Liu L; Cheng H
Drug Metab Dispos; 1996 Jul; 24(7):786-91. PubMed ID: 8818577
[TBL] [Abstract][Full Text] [Related]
40. Competition between cytochrome P-450 isozymes for NADPH-cytochrome P-450 oxidoreductase affects drug metabolism.
Li DN; Pritchard MP; Hanlon SP; Burchell B; Wolf CR; Friedberg T
J Pharmacol Exp Ther; 1999 May; 289(2):661-7. PubMed ID: 10215637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]